Table 7

Albuterol compared with pirbuterol: Demographic and study characteristics of included efficacy and effectiveness studies

Author
Year
Study durationInterventionNMean age in years (SD)% FemaleOther medications permitted during the studyQualityFunder
Adult asthma
Beumer
1980

Beumer
1979
Single doseAlbuterol 200 μg MDI

Pirbuterol 200 μg MDI
Pirbuterol 400 μg MDI
Pirbuterol 600 μg MDI
1257.60%Oral salbutamol (9 patients), antihistamine (3), oxtriphylline (92), salbutamol aerosol (1), fenoterol tablets (1), bronchodilators (unspecified)PoorNot reported
Pediatric asthma
Volkl
1991
Single doseAlbuterol 0.1 mg MDI

Pirbuterol 0.2 mg BAI
179.8 (1.5)47%No inhalational drug apart from the test preparations was allowed. Patients’ other therapies were unchanged during the study.FairNot reported

Abbreviations: MDI, metered dose inhaler.

From: Results

Cover of Drug Class Review: Quick-relief Medications for Asthma
Drug Class Review: Quick-relief Medications for Asthma: Final Report Update 1 [Internet].
Norris SL, McNally TK, Thakurta S.
Portland (OR): Oregon Health & Science University; 2008 Oct.
Copyright © 2008, Oregon Health & Science University, Portland, Oregon.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.